Quality Reports in Cancer Treatment

Cancer is the second-leading cause of death among Americans. It describes diseases in which abnormal cells divide without control and are able to invade other tissues. Adherence to and consideration of, standard of care therapies for cancer is important in order to achieve the best outcomes. PHCQA's Cancer Care data comes from the Commission on Cancer (CoC) of the American College of Surgeons, a nationally recognized multidisciplinary accreditation program.

The CoC's Cancer Program Practice Profile Reports (CP3R) offer CoC-Accredited cancer programs a platform from which to promote continuous practice improvement of quality of patient care and also permits hospitals to compare their care for cancer patients relative to that of other providers. The goal is to identify potential gaps in care and delivery and to implement the best practices that will diminish disparities in cancer care. (Source: American College of Surgeons)

*Information from Pennsylvania Health Care Quality Alliance

Radiation Therapy

Radiation therapy is administered within one year of diagnosis for women under the age of 70 receiving breast conservation surgery for breast cancer.

*2015* Percentage of female patients, age 18-69, who have their first diagnosis of breast cancer (epithelial malignancy), at AJCC state I, II, or III

Combination Chemotherapy

Combination chemotherapy is considered or administered within four months of diagnosis for women under 70 with T1cN0M0, or stage II or III hormone receptor negative breast cancer.

*2015* Percentage of female patients, over the age of 18-69 at diagnosis, who have their first diagnosis of breast cancer (epithelial malignancy), at AJCC state T1c, or Stage II or III

Tamoxifen

Tamoxifen or third generation aromatase inhibitor is considered or administered within one year of diagnosis for women with T1cN0M0, or stage II or III hormone receptor positive breast cancer.

*2015* Percentage of female patients, over the age of 18 at diagnosis, who have their first diagnosis of breast cancer (epithelial malignancy), at AJCC stage I, II, or III

Lymph Node Removal

At least 12 regional lymph nodes are removed and pathologically examined for resected colon cancer.

*2015* Percentage of patients, over the age of 18, who have primary colon tumors (epithelial malignancies only), experiencing their first diagnosis, at AJCC stage I, II, or III

Adjuvant Chemotherapy

Adjuvant chemotherapy is considered or administered within four months of diagnosis for patients under the age of 80 with stage III (lymph node positive) colon cancer.

*2015* Percentage of patients age 18-79, experiencing their first diagnosis, at AJCC III (lymph node positive) colon cancer for whom adjuvant chemotherapy is considered or administered within 4 months

For more information, visit PHCQA Report of Hospital Quality.

As a leader in cancer research, the Cancer Center at UPMC Susquehanna publishes quality reports that reflect our excellence in cancer treatment in Williamsport and Wellsboro, PA.